Search

everythinglearnresearchcommunity

for

Search:↓

A special foam called EG7 PTK-UR helps heal skin wounds better than other similar materials, working as well as a top-rated product and better than a polyester foam.

The hydrogel is versatile and easy to make.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Certain drugs that block specific enzymes can help treat prostate diseases.

Combining tadalafil and finasteride improves their solubility and effectiveness.

Researchers created a new, efficient way to make Dutasteride, a hair loss and prostate drug, with high purity using a benzoyl group.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Finasteride may help treat Pseudomonas aeruginosa infections by reducing its harmful activities.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

The improved process makes Finasteride suitable for industrial production.

New method makes important drug ingredients more easily without needing extra purification steps.

Tet1/2/3 enzymes affect hair follicle cell development by influencing BMP signaling.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Cyclodextrins improve finasteride's solubility and bioavailability for hair loss treatment.

Light-activated hyaluronic acid derivatives can enhance skin healing and regeneration.

The hydrogel speeds up diabetic wound healing by reducing inflammation and promoting skin repair.

Reactive lipids from aging cells change the extracellular matrix, affecting cell function and inflammation.

Chitosan-decorated carriers may improve topical finasteride delivery for hair loss treatment.

Repurposing existing drugs can quickly and cheaply find new treatments for unmet medical needs.